Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Chembiochem : a European Journal of Chemical Biology|August 27, 2019
Ubiquitin C-Terminal Hydrolase L1: Biochemical and Cellular Characterization of a Covalent Cyanopyrrolidine-Based InhibitorAaron D Krabill, Hao Chen, Sajjad Hussain, et al.
Briefings in Bioinformatics|September 25, 2024
CDHu40: a novel marker gene set of neuroendocrine prostate cancerSheng Liu, Hye Seung Nam, Ziyu Zeng, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
CDHu40: a novel marker gene set of neuroendocrine prostate cancer (NEPC)Sheng Liu, Hye Seung Nam, Ziyu Zeng, et al.
Journal of Medicinal Chemistry|March 15, 2024
Covalent Fragment Screening and Optimization Identifies the Chloroacetohydrazide Scaffold as Inhibitors for Ubiquitin C-terminal Hydrolase L1Ryan D Imhoff, Rishi Patel, Muhammad Hassan Safdar, et al.
Recent Patents on Biomarkers|July 4, 2017
Detection of Lysyl Oxidase-Like 2 (LOXL2), a Biomarker of Metastasis from Breast Cancers Using Human Blood SamplesMetini Janyasupab, Ying-Hui Lee, Yuan Zhang, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
PBRM1-Dependent PBAF Targeting is Required for EMT and Metastasis in Breast CancerAlisha Dhiman, Mitchell G Ayers, Jamie L McCuiston, et al.
Breast Cancer Research : BCR|June 7, 2024
Hypoxia-mediated repression of pyruvate carboxylase drives immunosuppressionMichael F Coleman, Eylem Kulkoyluoglu Cotul, Alexander J Pfeil, et al.
Cancer Research|February 9, 2019
Spleen Tyrosine Kinase-Mediated Autophagy Is Required for Epithelial-Mesenchymal Plasticity and Metastasis in Breast CancerAparna Shinde, Shana D Hardy, Dongwook Kim, et al.
Molecular Cancer Therapeutics|December 30, 2021
Preclinical Development of the Class-I-Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid TumorsJennifer R Diamond, Todd M Pitts, Dana Ungermannova, et al.
NPJ Precision Oncology|July 3, 2025
Prevalence and biological impact of clinically relevant gene fusions in head and neck cancersEmily L Hoskins, Raven Vella, Julie W Reeser, et al.
Pageof 7